stockrow
Friday 6 November 2026
Export KIDS’s income statement to Excel — free account
OrthoPediatrics Corp.
KIDS Healthcare Medical Devices
OrthoPediatrics Corp.’s revenue for fiscal 2025 (year ended December 2025) was $236.3 million, up 15.4% from fiscal 2024.
- Revenue
- +18.6%
- EPS
- +50.9%
- Free cash flow
- +146.6%
- Total debt
- +0.99%
Quarter to September 2026, against a year earlier
31.61
0.61
−1.89%
Follow KIDS
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 4 | 4 |
+8 more TTM periods Free account |
| (9.84%) | (11.36%) | (11.57%) | (11.31%) | ||
| (6.76%) | (7.83%) | (8.16%) | (8.08%) | ||
ROIC |
(3.95%) | (4.77%) | (5.94%) | (6.44%) | |
Return on Tangible Assets |
(13.86%) | (16.01%) | (16.05%) | (15.26%) | |
Average Days of Receivables |
82.28 | 88.03 | 81.66 | 83.14 | |
Free Cash Flow per Share |
0.13 | (0.08) | (0.53) | (0.68) | |
Free Cash Flow |
3.18 | (1.83) | (12.62) | (15.96) | |
Capital Expenditures |
(9.31) | (9.24) | (8.64) | (11.11) | |
| Other line items | |||||
Cash ROIC |
0.66% | (0.38%) | (2.59%) | (3.15%) | |
Accounts Receivable Turnover |
4.77 | 4.40 | 4.94 | 4.91 | |
Accounts Payable Turnover |
4.38 | 3.81 | 3.86 | 4.60 | |
Inventory Turnover |
0.51 | 0.51 | 0.52 | 0.51 | |
Average Days of Payables |
128.97 | 121.90 | 109.77 | 107.67 | |
Days of Inventory on Hand |
747.21 | 754.06 | 746.72 | 766.77 | |
Tax Rate |
0.01 | 0.01 | 0.00 | 0.01 | |
Research and Development Expense of Revenue |
3.51% | 3.62% | 3.69% | 3.85% | |
Selling, General and Administrative Expense of Revenue |
78.40% | 79.04% | 80.23% | 81.47% | |
Share Based Compensation of Revenue |
6.44% | 6.66% | 7.36% | 7.52% | |
Interest Coverage |
(2.70) | (3.58) | (5.25) | (6.54) | |
Operating CF/Net income |
(0.37) | (0.19) | 0.10 | 0.12 | |
Depreciation/Fixed assets |
0.55 | 0.59 | 0.58 | 0.56 | |
Capex/Depreciation |
(0.36) | (0.32) | (0.31) | (0.40) | |
Revenue per Share |
10.94 | 10.51 | 10.27 | 10.07 | |
Operating CF per Share |
0.52 | 0.31 | (0.17) | (0.21) | |
Capex per Share |
(0.39) | (0.38) | (0.36) | (0.47) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.05 |
Columns are period end dates · fundamentals updated 2 Nov 2026